Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 403–405 | Cite as

Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn’s disease

  • Katharina Amschler
  • Sigrid M. C. Broekaert
  • Johannes Mohr
  • Michael P. Schön
  • Rotraut Mößner
Correspondence
  • 16 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tauber M, Buche S, Reygagne P, et al. Alopecia areata occurring during anti–TNF therapy:a national multicenter prospective study. J Am Acad Dermatol 2014; 70: 1146–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Tillack C, Ehmann LM, Friedrich M, et al. Anti–TNF antibody–induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon–gamma–expressing Th1 cells and IL–17A/IL–22–expressing Th17 cells and respond to anti–IL–12/IL–23 antibody treatment. Gut 2014; 63: 567–77.CrossRefPubMedGoogle Scholar
  3. 3.
    Udkoff J, Cohen PR. Severe infliximab–induced alopecia and scalp psoriasis in a woman with crohn’s disease:dramatic improvement after drug discontinuation and treatment with adjuvant systemic and topical therapies. Dermatol Ther (Heidelb) 2016; 6: 689–95.CrossRefGoogle Scholar
  4. 4.
    Afanasiev OK, Zhang CZ, Ruhoy SM. TNF–inhibitor associated psoriatic alopecia:diagnostic utility of sebaceous lobule atrophy. J Cutan Pathol 2017; 44: 563–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Kreutzer K, Effendy I. Therapy–resistant folliculitis decalvans and lichen planopilaris successfully treated with adalimumab. J Dtsch Dermatol Ges 2014; 12: 74–6.PubMedGoogle Scholar
  6. 6.
    Mihaljevic N, von den Driesch P. Successful use of infliximab in a patient with recalcitrant folliculitis decalvans. J Dtsch Dermatol Ges 2012; 10: 589–90.PubMedGoogle Scholar
  7. 7.
    El Shabrawi–Caelen L, La Placa M, Vincenzi C, Haidn T, Muellegger R, Tosti A. Adalimumab–induced psoriasis of the scalp with diffuse alopecia:a severe potentially irreversible cutaneous side effect of TNF–alpha blockers. Inflamm Bowel Dis 2010; 16: 182–3.CrossRefPubMedGoogle Scholar
  8. 8.
    Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW. Five cases of anti–tumor necrosis factor alpha–induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol 2012; 29: 454–9.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Katharina Amschler
    • 1
  • Sigrid M. C. Broekaert
    • 1
  • Johannes Mohr
    • 1
  • Michael P. Schön
    • 1
  • Rotraut Mößner
    • 1
  1. 1.Department of Dermatology, Venereology and AllergologyUniversity Medical CenterGöttingenGermany

Personalised recommendations